Filing Flows

Filing Flows › Kyntra Bio (KYNB) › Who owns the stock

Who owns Kyntra Bio (KYNB) stock

30 funds reported Kyntra Bio (KYNB) shares in their latest 13F filings, worth $9.1M in all. The largest holder is Armistice Capital, LLC ($3.0M). Last quarter 6 funds added to their stakes and 12 cut them.

Largest holders of KYNB (13F)Largest holders of KYNB (13F)Armistice Capital, LLC$3.0MVanguard Group$1.6MVanguard Capital Management LLC$1.2MAcadian Asset Management LLC$795KBlackRock$637KGeode Capital Management, LLC$326KHighTower Advisors, LLC$300KTwo Sigma Investments, LP$298KRenaissance Technologies LLC$204KVanguard Fiduciary Trust$182K

Largest holders (13F)

FundSharesValueChangeQuarter
Armistice Capital, LLC400,000$3.0Munchanged2026-06-30
Vanguard Group181,973$1.6Mdecrease2025-12-31
Vanguard Capital Management LLC159,950$1.2Mincrease2026-06-30
Acadian Asset Management LLC105,585$795Kunchanged2026-06-30
BlackRock84,330$637Kdecrease2026-06-30
Geode Capital Management, LLC43,219$326Kdecrease2026-06-30
HighTower Advisors, LLC39,746$300Kincrease2026-06-30
Two Sigma Investments, LP39,511$298Kdecrease2026-06-30
Renaissance Technologies LLC27,081$204Kdecrease2026-06-30
Vanguard Fiduciary Trust24,105$182Kincrease2026-06-30
Birchview Capital, LP22,566$170Kunchanged2026-06-30
State Street20,284$153Kunchanged2026-06-30
GSA Capital Partners LLP15,697$119Knew2026-06-30
UBS Group AG7,857$59Kdecrease2026-06-30
Group One Trading LLC4,406$33Kdecrease2026-06-30

Kyntra Bio's latest quarter

Kyntra Bio, Q1 2026: revenue $3.7M (+36% year over year), operating margin -369.7%, net loss $15.2M, operating cash flow −$13.9M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most KYNB stock?

By the latest 13F filings: Armistice Capital, LLC ($3.0M); Vanguard Group ($1.6M); Vanguard Capital Management LLC ($1.2M); Acadian Asset Management LLC ($795K); BlackRock ($637K).

What is the short interest in KYNB?

94,984 shares were sold short at the 2026-10-15 settlement, -5.05% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.